| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Evofosamide |
|---|
| Description | Evofosfamide (TH-302) is an anticancer agent that is a hypoxia-activated prodrug that is created by linking the hypoxia-seeking 2-nitroimidazole moiety to the cytotoxic bromo-isophosphoramide mustard (Br-IPM). When evofosfamide is delivered to hypoxic regions of tumors, the DNA cross-linking toxin, Br-IPM, is released leading to cell death. MW: 449.04. Purity ≥98% |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Phosphorodiamidic acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester; TH302; TH-302 |
|---|
| Gene, Accession, CAS # | CAS: 918633-87-1 |
|---|
| Catalog # | B1912-5 |
|---|
| Price | |
|---|
| Order / More Info | Evofosamide from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|